Emergent BioSolutions Inc (NYSE:EBS)

30.80
Delayed Data
As of May 22
 -0.28 / -0.90%
Today’s Change
19.31
Today|||52-Week Range
31.75
+13.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line16.1M18.1M32.0M44.0M
 
 
 
 
 
Depreciation9.4M11.2M19.0M32.5M
 
 
 
 
 
Total Other Cash Flow15.4M19.8M8.0M5.9M
 
 
 
 
 
Funds From Operations61.1M52.5M72.8M98.8M
 
 
 
 
 
Funds From/For Other Operating Expenses46.5M12.8M-24.1M-13.5M
 
 
 
 
 
Net Cash Flow - Operating Activities14.6M39.6M97.0M112.3M
 
 
 
 
 
 
InvestingIncrease In Investments-4.2M0.000.000.00
 
 
Decrease In Investments4.3M2.0M0.000.00
 
 
 
Capital Expenditures-54.0M-53.8M-42.0M-30.7M
 
 
 
 
 
Fixed Asset Disposal0.0011.8M0.00--
 
 
Net Assets From Acquisitions 0.000.00-25.9M-179.4M
 
 
 
Net Cash Flow Investing-54.0M-40.1M-67.9M-210.1M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings27.5M13.5M62.0M242.6M
 
 
 
 
 
Long Term Debt Reduction-15.5M-10.2M-62.8M-62.0M
 
 
 
 
 
Net Proceeds Stock Sale10.0M761.0K6.8M14.1M
 
 
 
 
 
Common Preferred Redeemed0.00-5.9M-213.0K-200.0K
 
 
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing2.2M1.8M3.1M6.0M
 
 
 
 
 
Other Uses - Financing10.0M1.7M348.0K1.6M
 
 
 
 
 
Net Cash Flow - Financing14.3M-1.8M8.6M198.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash1.0K1.0K-14.0K21.0K
 
 
 
 
 
 
Net Change In Cash-25.1M-2.2M37.7M101.1M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account